Introduction
The BSAC Guide to Sensitivity Testing was first published in 1991 and one of its most important sections was that dealing with breakpoints for clinically relevant bacteria. 4 These breakpoints have been used extensively to interpret MIC results and for single concentration 'breakpoint' tests. However, a criticism of the guidelines was that they did not provide a standardized method of disc diffusion testing with zone limits that correlated with these MIC breakpoints. The limitations of the widely used Stokes' comparative method were also a cause for concern.
The task of developing such a method of disc testing is immense, and the Working Party and the Council of the BSAC needed evidence that there was sufficient interest to warrant the investment required not only in the short term, but also for continuing support and development. This necessary confirmation was obtained from a questionnaire survey, 5 which indicated that 90.6% of UK laboratories would be prepared to switch to an upgraded disc test, and the development and 'field testing' of the standardized method was therefore undertaken. 6 Fortuitously, the introduction of the standardized method has coincided with the availability of automated zone measuring devices, which aid measuring and interpretation considerably. With laboratories using the same method there is a real opportunity to combine zone diameter data, so that levels of resistance in the UK and Ireland can be surveyed, and subtle changes in susceptibility detected.
The method, like all standardized disc tests, cannot be adapted by the user, with the exception that various methods of inoculum preparation can be used to achieve semi-confluent growth.
For microorganisms not included in this section, work is either ongoing (e.g. anaerobes) or reported elsewhere (e.g. mycobacteria). 7 1 Preparation of plates 1.1 Prepare Iso-Sensitest agar (ISA; Oxoid, Basingstoke, UK), or media shown to have the same performance as ISA, according to the manufacturer's instructions. Media for fastidious organisms are supplemented with 5% defibrinated horse blood or 5% defibrinated horse blood+20 mg/L b-nicotinamide adenine dinucleotide (NAD) that can be obtained from Mast Group (Merseyside, UK) as in Table 1. 1.2 Pour sufficient molten agar into sterile Petri dishes to give a depth of 4 ± 0.5 mm (25 mL in a 90 mm Petri dish). 1.3 Dry the surface of the agar to remove excess moisture. The length of time needed to dry the surface of the agar depends on whether a fan-assisted drying cabinet (approximately 5-10 min) or a "still air" incubator is used. Important: do not over-dry plates. 1.4 Ideally, the plates should be stored in vented plastic boxes at 8-108C before use. Storage can extend for up to 1 week. Alternatively the plates may be stored at 4-88C in sealed plastic bags. Acceptable methods of drying plates and durations of storage should be validated by individual laboratories as part of their quality assurance programme. In particular, tests should Methicillin/oxacillin/cefoxitin resistant strain. NB: The control strains listed include sensitive strains that have been chosen to monitor test performance, and resistant strains that can also be used to confirm that the method will detect a mechanism of resistance; for example, H. influenzae ATCC 49247 is resistant to blactam antibiotics. To minimize the risk of mutations store control strains at 2208C (not adequate for fastidious organisms) or preferably at 2708C, in glycerol broth, on beads. Ideally, two vials of each control should be stored, one as an 'in-use' supply, the other for archiving. Every week a bead from the 'in-use' vial should be subcultured on to appropriate non-selective media and checked for purity. From this pure culture, prepare one subculture for each of the following 7 days. Alternatively, for fastidious organisms that will not survive on plates for 7 days subculture the strain daily for no more than 6 days.
confirm that excess moisture is not produced in a sealed environment and that plates are not over-dried in an unsealed environment.
2 Selection of control organisms Table 2 should be included, as appropriate, with every batch of susceptibility tests.
The control strains listed in

Preparation of inoculum
An inoculum giving semi-confluent growth of colonies after overnight incubation should be used. A denser inoculum will result in reduced zones of inhibition and a decreased inoculum will have the opposite effect. Use of an inoculum that yields semi-confluent growth has the advantage that an incorrect inoculum can readily be seen. Figure 1 shows the acceptable range of densities.
The following method reliably gives semi-confluent growth. Other methods, such as photometric measurement of turbidity of suspensions, may be adequate but must be shown to be equivalent to the following. Thoroughly mix the McFarland standard to ensure that it is evenly suspended. Using matched cuvettes with a 1 cm light path and water as a blank standard, measure the absorbance in a spectrophotometer at a wavelength of 625 nm. The acceptable range for the turbidity standard is 0.08-0.13. Distribute the standard into screw-cap tubes of the same size and volume as those used to prepare the test inoculum. Seal the tubes tightly to prevent loss by evaporation. Store protected from light at room temperature. Vigorously agitate the turbidity standard on a vortex mixer before use. Standards may be stored for up to 6 months, after which time they should be discarded. Alternatively, prepared standards can be purchased (e.g. from bioMérieux, Basingstoke, UK), but commercial standards should be checked to ensure that absorbance is within the acceptable range-see above.
3.1.2 Inoculum preparation by the growth method (for nonfastidious organisms, e.g. Enterobacteriaceae, Pseudomonas spp. and staphylococci) Touch at least four morphologically similar colonies with a sterile loop. Transfer the growth into Iso-Sensitest broth or an equivalent that has been shown to have no adverse effect on the test. Incubate the broth with shaking at 35-378C, until the visible turbidity is equal to or greater than the 0.5 McFarland standard. Table 3 for details. These suspensions should be used within 15 min of preparation.
Photometric standardization of turbidity of suspensions
A photometric method of preparing inocula was described by Moosdeen et al. 9 and from this the following simplified procedure has been developed. All Enterobacteriaceae isolates should be tested with cefpodoxime or both cefotaxime (or ceftriaxone) and ceftazidime. Enterobacteriaceae with reduced susceptibility or resistance to cefpodoxime, ceftriaxone, cefotaxime or ceftazidime should be tested for the presence of ESBLs. Organisms inferred to have ESBLs should be reported resistant to all penicillins (except temocillin) and cephalosporins, including the fourth-generation cephalosporins cefepime and cefpirome. For serious infections, carbapenems (imipenem, meropenem and ertapenem) are consistently active and are the treatment of choice. Isolates of E. coli and Klebsiella spp. have been identified with ceftazidime MICs of 1 mg/L. These MICs are higher than the 'wild susceptible' population ($ 0.12 mg/L). These isolates do not possess extended-spectrum b-lactamases, and until a mechanism of resistance has been identified this tentative zone diameter breakpoint is recommended. 3.3.1 Suspend colonies (touch 4-5 when possible) in 3 mL distilled water or broth in a 100 Â 12 mm glass tube (note that tubes are not reused) to give turbidity that is just visible. Do not leave the organisms standing in water. It is essential to get an even suspension. 3.3.2 Zero the spectrophotometer with a sterile water or broth blank (as appropriate) at a wavelength of 500 nm. Measure the optical density of the bacterial suspension. (The spectrophotometer must have a cellholder for 100 Â 12 mm test tubes. A much simpler photometer would also probably be acceptable. The 100 Â 12 mm test tubes could also be replaced with another tube/cuvette system if required, but the dilutions would need to be recalibrated.) 3.3.3 From Table 4 select the volume to transfer (with the appropriate fixed volume micropipette) to 5 mL sterile distilled water. (As different spectrophotometers may differ slightly, it may be necessary to adjust the dilutions slightly to achieve semi-confluent growth with any individual set of laboratory conditions.)
Inoculation of agar plates
Dip a sterile cotton-wool swab into the suspension and remove the excess liquid by turning the swab against the side of the tube. Spread the inoculum evenly over the entire surface of the plate by swabbing in three directions. Allow the plate to dry before applying discs. Note that if inoculated plates are left at room temperature for any length of time before the discs are applied, the organism may begin to grow, and this will result in reduced zones of inhibition. Discs should therefore be applied to the surface of the agar within 15 min of inoculation.
Use of Rotary platers for susceptibility testing
Rotary platers can be used for inoculating susceptibility tests but care must be taken. The swab must be moved at an even pace to ensure that the inoculum is semi confluent and that no gaps are present between the swab streaks.
5 Antimicrobial discs 5.1 Disc contents are given in Tables 6-19 .
Application of discs
Discs should be firmly applied to the surface of an agar plate that has been dried previously. The contact with the agar should be even. A 90 mm plate will accommodate six discs without unacceptable overlapping of zones.
Storage and handling of discs
Loss of potency from discs will result in reduced zones of inhibition. To avoid loss of potency as a result of improper handling the following procedures are essential. 5.3.1 Store discs in sealed containers with a desiccant and protect from light (this is particularly important for some light-susceptible agents such as metronidazole, chloramphenicol and the quinolones). 5.3.2 Store stocks at À208C except for drugs known to be unstable at this temperature. If this is not possible, store discs at <88C. 5.3.3 Store working supplies of discs at <88C.
5.3.4
To prevent condensation, allow discs to warm to room temperature before opening containers. 5.3.5 Store disc dispensers in sealed containers with an indicating desiccant. 5.3.6 Discard discs on the expiry date shown on the side of the container.
Incubation
6.1 If the plates are left at room temperature after discs have been applied, larger zones of inhibition may be obtained compared with zones produced when plates are incubated immediately. Plates therefore should be incubated within 15 min of disc application. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. The presence of blood has a marked effect on the activity of quinupristin/dalfopristin. On the rare occasions when blood needs to be added to enhance the growth of enterococci, susceptible = > _ 15 mm, resistant = < _ 14 mm. MIC breakpoint recommendations will follow. It is essential that plates be incubated for at least 24 h before reporting a strain as susceptible to vancomycin or teicoplanin.
Conditions of incubation
Conditions of incubation for different organisms are summarized in Table 5 . In general, avoid stacking plates more than six high in the incubator, as this may affect results owing to uneven heating of plates. However, incubators differ in their efficiency, and higher stacks are acceptable if it can be shown that they do not affect zone diameter.
Measuring zones and interpretation
7.1 Measure the diameters of zones of inhibition to the nearest millimetre (zone edge should be taken as the point of inhibition as judged by the naked eye) with a ruler, callipers or an automated zone reader. A template (Figure 2 ) can also be used for interpreting susceptibility (see 7.3). Tiny colonies at the edge of the zone, films of growth as a result of the swarming of Proteus spp. and slight growth within sulphonamide or trimethoprim zones should be ignored. Colonies growing within the zone of inhibition should be subcultured and identified and the test repeated if necessary. When using cefoxitin for the detection of methicillin/oxacillin/cefoxitin resistance in Staphylococcus aureus, measure the obvious zone, taking care to examine zones carefully in good light to detect minute colonies that may be present within the zone of inhibition. 7.2 Confirm that the zone of inhibition for the control strain falls within the acceptable ranges in Tables 20 -23 before interpreting the test. 7.3 A template can also be used for interpreting zone diameters ( Figure 2) . A program for preparing templates is available from the BSAC (http://www.bsac.org.uk). The test plate is placed over the template and the zones of inhibition are examined in relationship to the template zones. If the zone of inhibition of the test strain is within the area marked with an 'R', the organism is resistant. If the zone of inhibition is equal to or larger than the marked area, the organism is susceptible.
8 Direct susceptibility testing
Direct susceptibility testing of urines
The Working Party does not advocate direct susceptibility testing, as the control of inoculum is impossible. However, we are aware that this is a common practice in many laboratories and therefore we are suggesting methods that will achieve the correct inoculum size for a reasonable proportion of infected urines. The following methods have been developed and recommended by laboratories that use the BSAC method and we suggest adopting whichever method best suits individual laboratory working practice. If the inoculum is not correct and growth is not semi-confluent, or the culture is mixed, the test must be repeated.
(i) Method 1: thoroughly mix the urine, place a 10 mL loop of urine in the centre of the susceptibility plate and spread with a dry swab.
(ii) Method 2: thoroughly mix the urine, then dip a sterile cotton-wool swab in the urine and remove excess. Make a cross in the centre of the susceptibility plate then spread with a sterile dry swab. If only small numbers of organisms are seen under Resistance to ceftriaxone has not been described; however, isolates with chromosomally encoded reduced susceptibility to penicillin have slightly reduced zones of inhibition with these antibiotics but remain susceptible. Results for isolates with reduced zones around ceftriaxone, cefotaxime and cefixime discs should be confirmed by MIC determinations. The MIC breakpoint has been lowered to ensure that isolates with reduced susceptibility to ciprofloxacin are detected.
d
Test for b-lactamase.
e Use tetracycline result to infer susceptibility to doxycycline. For epidemiological purposes, isolates with plasmid-mediated resistance to tetracycline may be distinguished from those with chromosomal resistance on the basis of zone diameters; isolates with plasmid-mediated resistance have no zones of inhibition and those with low-level chromosomal resistance have zones 14-26 mm.
the microscope, the initial cotton-wool swab may be used to inoculate and spread the susceptibility plate.
Direct susceptibility testing of positive blood cultures
The Working Party does not recommend direct susceptibility testing of positive blood cultures. However, we are aware that this is common practice in many laboratories and therefore suggest a method that gives the correct inoculum size for a reasonable proportion of positive blood cultures. The method varies according to the Gram reaction of the infecting organism.
Gram-negative bacilli
Using a venting needle, place one drop in 5 mL of sterile water and use this to inoculate Iso-Sensitest or equivalent agar.
Gram-positive organisms
It is not always possible to accurately assume the genera of Gram-positive organisms from the Gram's stain However, For advice on testing susceptibility to co-trimoxazole see Appendix 3. g Based on sulfamethoxazole MIC. h The mode telithromycin MIC for these organisms is 1 mg/L and therefore the majority of isolates will be interpreted as having intermediate susceptibility. The information in italics is tentative. Breakpoints will remain tentative for 1 year from when first published. a Quinolone resistance is most reliably detected with nalidixic acid. If an organism is isolated from multiple sites, for example from blood and urine, interpretation of susceptibility should be made with regard to the systemic site; that is, if the blood isolate is resistant and the urine isolate susceptible, both should be reported similarly (resistant) irrespective of the results obtained using interpretative criteria for the urine isolates. For agents not listed criteria given for systemic isolates may be used for urinary tract isolates (see Tables 5 and 6 ). If an organism is isolated from multiple sites, for example from blood and urine, interpretation of susceptibility should be made with regard to the systemic site, that is, if the blood isolate is resistant and the urine isolate susceptible, both should be reported similarly (resistant) irrespective of the results obtained using interpretative criteria for the urine isolates. For 'coliforms' isolated from urinary tract infections the MIC breakpoint remains the same, but to improve reproducibility in disc diffusion tests the zone diameter breakpoints for ampicillin, amoxicillin and co-amoxiclav have been amended so that a zone diameter > _ 12 mm = susceptible with amoxicillin 25 mg, ampicillin 25 mg and co-amoxiclav 20/10 mg disc contents.
Review of the zone diameter breakpoints for piperacillin/ tazobactam for interpreting the susceptibility of Enterobacteriaceae
Data from a recent study in the UK and Ireland where susceptibility to piperacillin/tazobactam was determined by the BSAC standardized disc diffusion method have been reviewed by the BSAC Working Party on Susceptibility Testing. In this study, 5% of the isolates and all resistant organisms were sent to a central laboratory for testing. Scattergram plots of MIC versus the zone diameter (mm) were constructed. To reduce the number of isolates falsely interpreted as resistant to piperacillin/ tazobactam, the zone diameter breakpoints have been changed from susceptible = > _ 24 mm, resistant = < _ 23 mm to susceptible = > _ 22 mm, resistant = <21 mm.
Advice on testing the susceptibility to co-trimoxazole is provided; however, the following are the UK Committee on the Safety of Medicines (CSM) recommendations 'Co-trimoxazole should be limited to the role of drug of choice in Pneumocystis carinii pneumonia, it is also indicated for toxoplasmosis and nocardiasis. It should now only be considered for use in acute exacerbations of chronic bronchitis and infections of the urinary tract when there is good bacteriological evidence of sensitivity to co-trimoxazole and good reason to prefer this combination to a single antibiotic; similarly, it should only be used in acute otitis media in children when there is good reason to prefer it. Review of the safety of co-trimoxazole using spontaneous adverse drug reaction data has indicated that the profile of reported adverse reactions with trimethoprim is similar to that with co-trimoxazole; blood and generalized skin disorders are the most serious reactions with both drugs, and predominantly have been reported to occur in elderly patients. A recent large postmarketing study has demonstrated that such reactions are very rare with co-trimoxazole; the study did not distinguish between co-trimoxazole and trimethoprim with respect to serious hepatic, renal, blood or skin disorders.'
Appendix 4. Susceptibility testing H. influenzae to b-lactam antibiotics
During the last year, several users of the method have reported problems when testing susceptibility of clinical isolates of H. influenzae to b-lactam antibiotics. Of particular concern was coamoxiclav, with which many b-lactamase-positive isolates had zone diameters 1-2 mm smaller than the zone diameter breakpoint of 20 mm and were therefore incorrectly interpreted as resistant.
The problem was further highlighted by results with NEQAS specimen 5853. This b-lactamase-positive isolate has a co-amoxiclav MIC of 0.5 mg/L. Amongst the laboratories that incorrectly interpreted this organism as being resistant to co-amoxiclav, centres using the BSAC method were common, and they reported zone diameters of 18 -19 mm for the organism with coamoxiclav.
The Working Party therefore reviewed the zone diameter breakpoints for ampicillin, amoxicillin, co-amoxiclav and cefuroxime and recommendations for the interpretation of susceptibility of H. influenzae are as follows: 
